SI-BONE: 3 Key Takeaways for Long-Term Investors

Source Motley_fool

Key Points

  • Worldwide revenue increased 15% to $55.7 million in the third quarter.

  • The iFuse Granite Onyx clearance expands the addressable market to $5 billion.

  • Active physicians grew 16% year over year to 1,770 doctors.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

On its third-quarter 2026 earnings call, held on Nov. 2, 2026, SI-BONE (NASDAQ:SIBN) announced a 15% increase in worldwide revenue to $55.7 million, driven by expanding adoption of its surgical implants. The medical device maker is extending its anatomical fixation products into wider spinal applications, positioning itself to capture a larger share of complex surgeries.

Three things management said stand out.

1. The Launch of Onyx Expands Market Opportunity to $5 Billion

Management launched iFuse Granite Onyx, a medical device designed to fix spinal fusion failures, following clearance from the Food and Drug Administration (FDA). This product extends the company's addressable market by targeting procedures that suffer from high failure rates.

The addition of Onyx increases our estimated total addressable market to over 650,000 procedures, representing an annual total market opportunity of approximately $5 billion.
-- Laura Francis, Chief Executive Officer

2. Higher Reimbursement Rates Provide a Catalyst for Hospital Adoption

Updated Medicare severity diagnosis-related groups (DRGs), which define fixed payment rates for hospital stays, took effect in October to cover complex spinal surgeries. Higher reimbursement reduces financial hurdles for surgical centers, paving the way for wider platform adoption.

Depending on patient diagnosis and severity, the increase in the average hospital payment could be up to $50,000 per qualifying procedure.
-- Laura Francis, Chief Executive Officer

3. A Growing Active Physician Base Strengthens Commercial Reach

The commercial network expanded to 1,770 active doctors performing procedures, representing a 16% increase year over year. A broader physician footprint gives the company immediate access to cross-sell new device lines without expanding overhead at the same rate.

When Granite launched in 2022, we had over 700 active physicians... Today, we have approximately 1,770 active physicians and over 300 agents.
-- Laura Francis, Chief Executive Officer

Looking Ahead

Procedure demand is accelerating across surgical centers, and executive leadership is displaying clear momentum.

We delivered a solid third quarter with accelerating procedure demand, broader physician adoption and improving financial performance.
-- Laura Francis, Chief Executive Officer

The company relies on custom implant engineering and established training networks to shield its platform from rivals. Management is keeping close watch on pricing discipline and sales productivity as product launches roll out.

Looking ahead, we're very confident in our ability to accelerate growth, improve profitability and help more patients achieve better outcomes.
-- Laura Francis, Chief Executive Officer

Should you buy stock in SI-Bone right now?

Before you buy stock in SI-Bone, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SI-Bone wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $305,941!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $771,325!*

Now, it’s worth noting Stock Advisor’s total average return is 719% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 22, 2026.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Today: Can XAU/USD Hold $3,500? | Mitrade AUGold approaches US$3,500 as Fed tightening fears drive sharp weekly losses. Explore XAU/USD levels, Treasury yields and the outlook for Australian traders.
Author  Mitrade Team
Nov 20, Fri
Gold approaches US$3,500 as Fed tightening fears drive sharp weekly losses. Explore XAU/USD levels, Treasury yields and the outlook for Australian traders.
placeholder
Australia’s jobs market just cracked — has the AUD/USD rate story flipped?Australia’s weakening jobs market is raising fresh questions about the RBA’s interest rate outlook and the Australian dollar. Explore why AUD/USD could be losing support, the key factors driving currency movements and what Australian forex traders should watch next.
Author  Mark Garro
Nov 20, Fri
Australia’s weakening jobs market is raising fresh questions about the RBA’s interest rate outlook and the Australian dollar. Explore why AUD/USD could be losing support, the key factors driving currency movements and what Australian forex traders should watch next.
placeholder
Market News Today Australia: VIX Surges Nearly 16%, Gold Breaks US$3,600 and US Stocks SlideVIX jumps 15.8%, Nasdaq 100 falls 2.21% and gold slips below US$3,600. Explore Anthropic’s debut and the outlook for Australian CFD traders.
Author  Mitrade Team
Nov 20, Fri
VIX jumps 15.8%, Nasdaq 100 falls 2.21% and gold slips below US$3,600. Explore Anthropic’s debut and the outlook for Australian CFD traders.
placeholder
Is Tech in a Bear Market? 20 Tech Stocks Fall Up to 76% From HighsAll 20 tech stocks on a list from financial newsletter The Kobeissi Letter trade at least 25% below record highs. CoreWeave (CRWV) leads the slide at 76%.Additionally, the S&P 500 has lost over $6 tri
Author  Beincrypto
Nov 20, Fri
All 20 tech stocks on a list from financial newsletter The Kobeissi Letter trade at least 25% below record highs. CoreWeave (CRWV) leads the slide at 76%.Additionally, the S&P 500 has lost over $6 tri
placeholder
Gold and Bitcoin Are Falling. Peter Schiff Sees Opportunities for BothPeter Schiff says gold should not have fallen at all, while Bitcoin (BTC) has not fallen enough. The gold advocate calls the metal’s drop a buying opportunity and Bitcoin’s a selling opportunity.Both
Author  Beincrypto
Nov 20, Fri
Peter Schiff says gold should not have fallen at all, while Bitcoin (BTC) has not fallen enough. The gold advocate calls the metal’s drop a buying opportunity and Bitcoin’s a selling opportunity.Both
goTop
quote